{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:44:09Z","timestamp":1791776649253,"version":"4.3.4"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Red blood cell (RBC) antigen matching beyond ABO and RhD is commonly recommended for patients with sickle cell disease (SCD) and thalassaemia. We present an updated systematic literature review to inform evidence\u2010based guidelines on RBC matching. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool was used to develop recommendations. Six new observational studies (4 prospective, 2 retrospective) were identified. The six studies reported on 583 patients in total, including cross\u2010over designs, with sample sizes from 10 to 343. Studies were heterogeneous, utilising varying degrees of RBC matching and different definitions for \u2018extended\u2019 matching. All reported on alloimmunisation. One study reported on molecular matching. The reported prevalence of alloimmunisation using limited matching was 0%\u201350% and with extended matching was 0%\u201324%. Eighty\u2010two patients were alloimmunised before study entry. The risk of bias across studies was moderate to critical. The guideline panel recommends that ABO, RhDCcEe, and K\u2010compatible RBCs are selected for individuals with SCD and thalassaemia, even in the absence of alloantibodies, and that RBCs which are antigen\u2010negative to already existing clinically significant antibodies are chosen. There is a need for comparative research to define the benefit, impact, cost\u2010effectiveness, and feasibility of extended RBC matching strategies to prevent alloimmunisation.<\/jats:p>","DOI":"10.1111\/bjh.19837","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T06:48:57Z","timestamp":1731480537000},"page":"94-108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines"],"prefix":"10.1111","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-508X","authenticated-orcid":false,"given":"Julia","family":"Wolf","sequence":"first","affiliation":[{"name":"Bristol Haematology and Oncology Centre  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Blais\u2010Normandin","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Vancouver British Columbia Canada"},{"name":"Universit\u00e9 Laval  Qu\u00e9bec Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Bathla","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Keshavarz","sequence":"additional","affiliation":[{"name":"Canadian Blood Services  Ottawa Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella T.","family":"Chou","sequence":"additional","affiliation":[{"name":"Division of Hematology The Children's Hospital of Philadelphia  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-0650","authenticated-orcid":false,"given":"Arwa Z.","family":"Al\u2010Riyami","sequence":"additional","affiliation":[{"name":"Department of Hematology Sultan Qaboos University Hospital, University Medical City  Al Koudh Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[{"name":"Department of Oncology and Pediatrics Johns Hopkins University School of Medicine, Johns Hopkins All Children's Hospital  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Massey","sequence":"additional","affiliation":[{"name":"Welsh Blood Service Velindre University NHS Trust  Pontyclun Wales UK"},{"name":"Cwm Taf Morgannwg University Health Board  Pontyclun Wales UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Hume","sequence":"additional","affiliation":[{"name":"D\u00e9partement de P\u00e9diatrie Universit\u00e9 de Montr\u00e9al, Service d'H\u00e9matologie\/Oncologie, CHU Sainte\u2010Justine  Montr\u00e9al Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Pendergrast","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology University of Toronto, University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-1679","authenticated-orcid":false,"given":"Gregory","family":"Denomme","sequence":"additional","affiliation":[{"name":"Grifols Laboratory Solutions  San Marcos Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4885-3323","authenticated-orcid":false,"given":"Rada M.","family":"Grubovic Rastvorceva","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine of RNM  Skopje North Macedonia"},{"name":"Faculty of Medical Sciences, University Goce Delcev  Stip North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-8449","authenticated-orcid":false,"given":"Sara","family":"Trompeter","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant  London UK"},{"name":"University College London  London UK"},{"name":"University College London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-4950","authenticated-orcid":false,"given":"Simon J.","family":"Stanworth","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant  Oxford UK"},{"name":"Oxford University Hospitals NHS Trust  Oxford UK"},{"name":"University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the International Collaboration for Transfusion Medicine Guidelines (ICTMG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.270546"},{"issue":"1","key":"e_1_2_11_3_1","first-page":"4","article-title":"Red blood cell alloimmunisation in transfusion\u2010dependent thalassaemia: a systematic review","volume":"17","author":"Franchini M","year":"2019","journal-title":"Blood Transfus"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2019.102678"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100588"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14611"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16405"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5535"},{"key":"e_1_2_11_10_1","unstructured":"ROBINS\u2010I tool. Cochrane methods. Available from:https:\/\/methods.cochrane.org\/robins\u2010i"},{"key":"e_1_2_11_11_1","unstructured":"GRADE approach\u2014Cochrane training. Available from:https:\/\/training.cochrane.org\/grade\u2010approach"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.21307\/immunohematology-2020-053"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15599"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2018.11.006"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14588"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15002"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2017.01.003"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001894"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30053-X"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01625.x"},{"key":"e_1_2_11_22_1","unstructured":"ISBT The International Society of Blood Transfusion (ISBT).Red Cell Immunogenetics and Blood Group Terminology. Available from:https:\/\/www.isbtweb.org\/isbt\u2010working\u2010parties\/rcibgt.html"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12987"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40030310.x"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00118-7"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15280"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.06.003"},{"key":"e_1_2_11_28_1","unstructured":"World Health Organization.Educational modules on clinical use of blood.2021. Available from:https:\/\/iris.who.int\/handle\/10665\/350246"},{"issue":"1","key":"e_1_2_11_29_1","first-page":"5","article-title":"Abstract P\u2010007\u2014applicability of international guidelines for red cell specifications for use in low\u2010resource settings","volume":"116","author":"Charg\u00e9 S","year":"2021","journal-title":"Vox Sang"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v21i2.38"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.645"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T02:08:12Z","timestamp":1749607692000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/bjh.19837"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19837","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"2024-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}